Author

Duaa Kanan

Observed name: D. Kanan

Institutions: Bahçeşehir University, Peoria campus of the University of Illinois System

Observed institutions: Bahçeşehir University, Peoria campus of the University of Illinois System

ORCID: 0000-0003-1943-8371

Observed ORCID: 0000-0003-1943-8371

OpenAlex ID: A5076727043

Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models

2018 · Tarek Kanan, Duaa Kanan, et al. · Journal of Molecular Graphics and Modelling · 31

An Integrated in silico Approach and in vitro Study for the Discovery of Small‐Molecule USP7 Inhibitors as Potential Cancer Therapies

2020 · Duaa Kanan, Tarek Kanan, et al. · ChemMedChem · 20

Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model

2021 · Tarek Kanan, Duaa Kanan, et al. · Journal of Molecular Graphics and Modelling · 15

Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma

2021 · Serkan Çelik, Bala Başak Öven, et al. · Clinical Neurology and Neurosurgery · 10

Young lung cancer: from diagnosis to survivorship

2025 · Narjust Florez, Lauren Kiel, et al. · Frontiers in Oncology · 6

Targeting Ubiquitin-Specific Protease 7 (USP7): A Pharmacophore-Guided Drug Repurposing and Physics-Based Molecular Simulation Study

2025 · Duaa Kanan, Tarek Kanan, et al. · ACS Omega · 3

Diffuse Leptomeningeal Glioneuronal Tumors: A Case Series of Five Patients with Parenchymal Forms and an Analysis of the Diagnostic Challenges, Treatment Options and Outcomes

2023 · Mustafa Kemal Demir, Ozlem Yapıcıer, et al. · Current Medical Imaging Formerly Current Medical Imaging Reviews · 3

Integrated diagnosis of grade 3-4 gliomas using targeted next-generation sequencing and traditional diagnostic data, and its overall implications on patient management

2024 · Duaa Kanan, Şebnem Safi, et al. · Brain Disorders · 2

Outcomes of hospitalized patients with hyperferritinemia and hematologic malignancies: A single-center retrospective analysis

2025 · Rishi Bothara, Duaa Kanan, et al. · Blood · 1

Impact of the tumor proportion score (TPS) and the combined positive score (CPS) on the use of immunotherapy in patients with metastatic non-small cell lung cancer.

2024 · Duaa Kanan, Tarek Kanan, et al. · Journal of Clinical Oncology · 1

Integration of traditional molecular diagnostic tools and targeted next generation sequencing for the precise diagnosis and management of adult gliomas.

2022 · Duaa Kanan, Şebnem Safı, et al. · Journal of Clinical Oncology · 1

Integrating Advanced Computational and Artificial Intelligence-based Methodologies for the Discovery of Ubiquitin Specific Protease 21 (USP21) Inhibitors as Lung Cancer Therapeutics: An FDA-approved and Investigational Drug Repurposing Study

2025 · T. Kanan, D. Kanan, et al. · American Journal of Respiratory and Critical Care Medicine

Abstract 277: Discovery of promising antineoplastic drugs against the USP7 deubiquitinating enzyme: A pharmacophore-based FDA-approved and investigational drugs repurposing study

2021 · Duaa Kanan, Tarek Kanan, et al. · Cancer Research

Design, implementation, and assessment of an online-based oncology education program for medical students: An ASCO Oncology Student Interest Group initiative.

2021 · Duaa Kanan, Tarek Kanan, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 93

H-index: 5

I10-index: 4